Cargando…
SATB2 is a novel biomarker and therapeutic target for cancer
Several studies have confirmed the involvement of cancer stem cells (CSC) in tumour progression, metastasis, drug resistance and cancer relapse. SATB2 (special AT‐rich binding protein‐2) acts as a transcriptional co‐factor and modulates chromatin architecture to regulate gene expression. The purpose...
Autores principales: | Roy, Sanjit K., Shrivastava, Anju, Srivastav, Sudesh, Shankar, Sharmila, Srivastava, Rakesh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576221/ https://www.ncbi.nlm.nih.gov/pubmed/32885593 http://dx.doi.org/10.1111/jcmm.15755 |
Ejemplares similares
-
Riluzole regulates pancreatic cancer cell metabolism by suppressing the Wnt-β-catenin pathway
por: Roy, Sanjit K., et al.
Publicado: (2022) -
Role of SATB2 in human pancreatic cancer: Implications in transformation and a promising biomarker
por: Yu, Wei, et al.
Publicado: (2016) -
Higher expression of SATB2 in hepatocellular carcinoma of African Americans determines more aggressive phenotypes than those of Caucasian Americans
por: Yu, Wei, et al.
Publicado: (2019) -
Chronic alcohol exposure induces hepatocyte damage by inducing oxidative stress, SATB2 and stem cell‐like characteristics, and activating lipogenesis
por: Yu, Wei, et al.
Publicado: (2022) -
SATB2/β-catenin/TCF-LEF pathway induces cellular transformation by generating cancer stem cells in colorectal cancer
por: Yu, Wei, et al.
Publicado: (2017)